Nataša Smrekar
2PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Feb 24, 2024
Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease.Špela Pintar, Jurij Hanžel, David Drobne
|Oct 23, 2021
Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model.Jurij Aguiar Zdovc, Jurij Hanžel, Tina Kurent
Pageof 1
